Source: The Business Journals: Boston

Solace Therapeutics: Solace Therapeutics, a Framingham-based medical device company focused on bladder disorders, raised $2.5M in equity in a $17.6M funding round, per an SEC filing.

Solace Therapeutics, a Framingham-based medical device company focused on bladder disorders, raised $2.5M in equity in a $17.6M funding round, per an SEC filing.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Bill Gruber's photo - President & CEO of Solace Therapeutics

President & CEO

Bill Gruber

CEO Approval Rating

87/100

Read more